ADS Biotec Announces Immediate Availability of FDA-EUA Authorized COVID-19 Antibody Detection Kits
Bio Nebraska member ADS Biotec announces availability of COVID-19 Antibody kits that detect coronavirus antibodies in human blood samples. Read more
$70 million expansion will help Nebraska facilities play a key role in COVID-19 vaccine
Omaha World-Herald staff writer Erin Duffy covers Bio Nebraska member, BD, and their expansion’s role in the fight against COVID-19. Read more
Amgen CEO Featured in Forbes
Bio Nebraska member, Amgen, talks to Fortune about testing drugs and beginning clinical trials to treat symptoms of COVID-19. Read more
LI-COR Near-Infrared Assays and Technology Offer Insight to Coronavirus Researchers
LI-COR Biosciences, Bio Nebraska member, continues to support virology researchers with products, tools, and services to better understand COVID-19. Read more
Welcome Staska Pharmaceuticals
We are excited to welcome Staska Pharmaceuticals as a new Bio Nebraska member! Read more
Member Spotlight: University of Nebraska
President Ted Carter talks about his first six months leading the University of Nebraska in the face of COVID-19. Read more
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Bio Nebraska member, Pfizer, and BioNTech announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program. Read more
University of Nebraska among world’s top 100 in earning U.S. patents
For the third straight year, the University of Nebraska system is ranked among the top 100 academic institutions worldwide in earning U.S. patents. Read more